Peter recently spoke with the publication Scientific American about the challenges of working with Rhinovirus, the primary causative agent of the common cold, and the potential for a cure to be developed.
In the article by writer Angus Chen, entitled “Why haven’t we cured the common cold yet?“, Peter talks about the large number of circulating strains of rhinovirus, as well as some exciting approaches being employed by scientists in terms of either preventing or treating this infection.
The article touches upon the work of Filipa Henderson Sousa and Dr Victor Casanova, previous members of Peter’s research group who have been working on peptide based therapeutic options for rhinovirus.
Peter also talks about the implications of developing a cure for the common cold, and whether this would ever be rolled out to be an over the counter therapy.
Read the article now at Scientific American
